Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.18 - $2.32 $219 - $431
-186 Reduced 1.49%
12,276 $15,000
Q3 2022

Nov 14, 2022

SELL
$1.65 - $3.42 $55,692 - $115,435
-33,753 Reduced 73.03%
12,462 $24,000
Q1 2022

May 16, 2022

SELL
$3.01 - $4.81 $14,806 - $23,660
-4,919 Reduced 9.62%
46,215 $139,000
Q4 2021

Feb 14, 2022

SELL
$3.36 - $5.34 $15,519 - $24,665
-4,619 Reduced 8.28%
51,134 $231,000
Q3 2021

Nov 15, 2021

BUY
$3.3 - $6.49 $183,984 - $361,836
55,753 New
55,753 $310,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.